Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042362
Filing Date
2021-08-09
Accepted
2021-08-09 08:15:56
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hrtx-10q_20210630.htm   iXBRL 10-Q 2290334
2 EX-31.1 hrtx-ex311_8.htm EX-31.1 21771
3 EX-31.2 hrtx-ex312_7.htm EX-31.2 21064
4 EX-32.1 hrtx-ex321_6.htm EX-32.1 17906
  Complete submission text file 0001564590-21-042362.txt   7684993

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20210630.xsd EX-101.SCH 39640
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20210630_cal.xml EX-101.CAL 42352
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20210630_def.xml EX-101.DEF 136003
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20210630_lab.xml EX-101.LAB 349249
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20210630_pre.xml EX-101.PRE 257922
10 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-10q_20210630_htm.xml XML 1522000
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 211154731
SIC: 2834 Pharmaceutical Preparations